Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$446,874,011
+$113,305,099 QoQ
Shares Held
18,557,891
+56.2% QoQ
Ownership
0.326%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#32
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $6,352,612,055 across 16 Drug Manufacturers - General names. PFE ranks #6 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
27,357,486 | $1,576,338,337 | |
| 2 | LLY |
ELI LILLY & Co
|
1,035,605 | $1,242,135,802 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,134,262 | $1,045,252,665 | |
| 4 | JNJ |
Johnson & Johnson
|
2,907,803 | $738,494,723 | |
| 5 | ABBV |
AbbVie Inc.
|
2,015,238 | $507,114,486 | |
| 6 | PFE |
Pfizer Inc
This page
|
18,557,891 | $446,874,011 | |
| 7 | BIIB |
Biogen Inc.
|
1,936,859 | $418,477,751 | |
| 8 | AMGN |
Amgen Inc
|
300,007 | $108,638,532 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,874,011 | 18,557,891 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $333,568,912 | 11,879,235 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $244,513,838 | 9,819,833 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $242,203,067 | 9,505,615 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $104,298,195 | 4,302,731 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $153,983,118 | 6,076,682 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $177,719,083 | 6,698,797 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $48,528,964 | 1,676,882 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $17,135,762 | 612,429 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $16,733,083 | 602,994 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $50,089,417 | 1,739,820 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $170,599,875 | 5,143,198 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $198,280,635 | 5,405,688 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $382,819,300 | 9,382,826 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $504,192,530 | 9,839,823 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $467,587,940 | 10,685,282 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $553,910,104 | 10,564,755 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $554,119,884 | 10,703,494 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $404,240,296 | 6,845,729 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $243,210,367 | 5,654,740 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $211,569,535 | 5,402,695 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $192,894,063 | 5,324,153 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $158,056,397 | 4,293,844 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $290,078,201 | 7,904,046 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $325,171,882 | 9,944,084 | Shares | Other | 2020-08-17 | |
| 2020-03-31 | $361,174,817 | 11,065,420 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||